0O14.LSE MERCK Kommanditgesellschaft auf Aktien

Healthcare Commercial Services & Supplies London Exchange
- EUR
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
1.12%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2023.

Is 0O14.LSE undervalued?

Graham number

The Graham number of MERCK Kommanditgesellschaft auf Aktien cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MERCK Kommanditgesellschaft auf Aktien fundamental analysis

No fundamental analysis for MERCK Kommanditgesellschaft auf Aktien yet.

MERCK Kommanditgesellschaft auf Aktien stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MERCK Kommanditgesellschaft auf Aktien

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomo…

Full company profile